Cargando…

Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy

Ovarian cancer, a rare but fatal disease, has been a challenging area in the field of gynecological cancer. Ovarian cancer is characterized by peritoneal metastasis, which is facilitated by a cross-talk between tumor cells and other cells in the tumor microenvironment (TME). In epithelial ovarian ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Vijayalaxmi, Yull, Fiona, Khabele, Dineo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210537/ https://www.ncbi.nlm.nih.gov/pubmed/30274280 http://dx.doi.org/10.3390/cancers10100366

Ejemplares similares

Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2021)

Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model
por: Wilson, Andrew J, et al.
Publicado: (2013)

The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
por: Khabele, Dineo
Publicado: (2014)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
por: Jewell, Andrea, et al.
Publicado: (2018)

Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer
por: Hoover, Alyssa A., et al.
Publicado: (2020)

Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
por: Wilson, Andrew J, et al.
Publicado: (2012)

Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis
por: Hufnagel, Demetra H., et al.
Publicado: (2020)

Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer
por: Asem, Marwa, et al.
Publicado: (2020)

Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer
por: Glass, Evan B., et al.
Publicado: (2022)

Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
por: Schweer, David, et al.
Publicado: (2022)

Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors
por: Beeghly-Fadiel, Alicia, et al.
Publicado: (2018)

Disparities in ovarian cancer survival at the only NCI-designated cancer center in Kansas
por: Petersen, Shariska, et al.
Publicado: (2020)

Preferential Effect of Akt2-Dependent Signaling on the Cellular Viability of Ovarian Cancer Cells in Response to EGF
por: Khabele, Dineo, et al.
Publicado: (2014)

Augmented Serum Amyloid A1/2 Mediated by TNF-induced NF-κB in Human Serous Ovarian Epithelial Tumors
por: Choi, Hyeongjwa, et al.
Publicado: (2017)

Pharmacological ascorbate induces ‘BRCAness’ and enhances the effects of Poly(ADP-Ribose) polymerase inhibitors against BRCA1/2 wild-type ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020)

Blood type, ABO genetic variants, and ovarian cancer survival
por: Cozzi, Gabriella D., et al.
Publicado: (2017)

CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes
por: Petersen, Shariska, et al.
Publicado: (2020)

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
por: Truxova, Iva, et al.
Publicado: (2023)

Aspirin Blocks EGF-stimulated Cell Viability in a COX-1 Dependent Manner in Ovarian Cancer Cells
por: Cho, May, et al.
Publicado: (2013)

A Case of Extrauterine Endometrial Stromal Sarcoma in the Colon Diagnosed Three Decades after Hysterectomy for Benign Disease
por: Ayuso, Andres, et al.
Publicado: (2013)

Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment
por: Kumar, Sudhir, et al.
Publicado: (2022)

Adrenal Gland Metastasis Is an Unusual Manifestation of Endometrial Cancer
por: Zaidi, Syeda Sadia, et al.
Publicado: (2013)

Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records
por: Cozzi, Gabriella D., et al.
Publicado: (2016)

Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy
por: He, Yuanyuan, et al.
Publicado: (2021)

Tumor-Associated Macrophages as Target for Antitumor Therapy
por: Sawa-Wejksza, Katarzyna, et al.
Publicado: (2017)

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer
por: Nowak, Marek, et al.
Publicado: (2020)

Discovery of Furanone-Based Radiopharmaceuticals for Diagnostic Targeting of COX-1 in Ovarian Cancer
por: Uddin, Md. Jashim, et al.
Publicado: (2019)

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
por: Petty, Amy J., et al.
Publicado: (2021)

Targeting tumor-associated macrophages for cancer treatment
por: Li, Mengjun, et al.
Publicado: (2022)

Targeting FRβ+ tumor associated macrophages with car T cells in ovarian cancer
por: Lynn, Rachel C, et al.
Publicado: (2015)

Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
por: Yin, Meichen, et al.
Publicado: (2019)

Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers
por: Xu, Tianhan, et al.
Publicado: (2021)

Targeting tumor-associated macrophages to combat pancreatic cancer
por: Cui, Ran, et al.
Publicado: (2016)

Tumor-associated macrophages, potential targets for cancer treatment
por: Yang, Li, et al.
Publicado: (2017)

Human papillomavirus vaccination completion rates among gynecological providers: an institutional retrospective review
por: Elsamadicy, Emad A., et al.
Publicado: (2019)

Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies
por: Petty, Amy J., et al.
Publicado: (2019)

Targeting tumor-associated macrophages in the tumor microenvironment
por: Zhou, Kaiwen, et al.
Publicado: (2020)

Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer
por: Colvin, Emily K.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hrpu0qlcqe3dob45facldolmn0